CIK: 1853327 - Address: 221 Crescent Street, Building 23,, Suite 105, Waltham, MA 02453
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/3/26 21:32
3/3/26
SYRESpyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LMAOCFOM.d3614.5003398D
3/3/26 21:32
3/3/26
SYRESpyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LMAOCFOS.d-10240.650-3-298D
9/3/25 18:53
9/2/25
SYRESpyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LMAOCFOS-30016.260-18-1698D
9/5/24 16:04
9/3/24
SYRESpyre Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LMAOCFOS-52228.170-19-14116D
3/8/23 16:29
3/6/23
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LCAOCFOS-415.2600059D
3/2/23 19:05
2/28/23
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LCAOCFOS.m-2915.900-2-538D
9/20/22 16:37
9/16/22
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LCAOCFOM.d81.68051440D
3/7/22 20:49
3/4/22
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LCAOCFOS.dm-516.8500-135D
3/3/22 16:17
3/1/22
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LCAOCFOS-717.7500-222D
12/28/21 17:00
12/27/21
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBurrows Scott LCAOCFOS-25220.070-13-3623D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact